Gilead Sciences GILD NASDAQ:GILD

Biotech Bullish Stocks: Can Fite Biopharma (NYSEMKT:CANF), NanoString Technologies (NASDAQ:NSTG), Amicus Therapeutics (NASDAQ:FOLD), Oncolytics Biotech (NASDAQ:ONCY)

Can-Fite BioPharma Ltd. (NYSEMKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) stock performance was 11.80% in last session and finished the day at $5.78. Traded volume was 91.85K shares … Continue reading Biotech Bullish Stocks: Can Fite Biopharma (NYSEMKT:CANF), NanoString Technologies (NASDAQ:NSTG), Amicus Therapeutics (NASDAQ:FOLD), Oncolytics Biotech (NASDAQ:ONCY)

Kristen Barton04/0304/03

Biotech Decliners: Peregrine Pharmaceuticals (NASDAQ:PPHM), CytRx Corporation (NASDAQ:CYTR), PTC Therapeutics (NASDAQ:PTCT), Amicus Therapeutics (NASDAQ:FOLD)

Peregrine Pharmaceuticals (NASDAQ:PPHM) announced its earnings results on Friday. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06). Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was -8.05% in last session and finished the day at $2.40. Traded volume was 14.14million shares in the last session and the average volume of the stock remained 4.31million shares. The beta of the … Continue reading Biotech Decliners: Peregrine Pharmaceuticals (NASDAQ:PPHM), CytRx Corporation (NASDAQ:CYTR), PTC Therapeutics (NASDAQ:PTCT), Amicus Therapeutics (NASDAQ:FOLD)

Kristen Barton03/1003/10

News Buzz: America Movil (NYSE:AMX), Verizon Communications Inc. (NYSE:VZ), Amicus Therapeutics, Inc. (NASDAQ:FOLD), Dime Community Bancshares Inc. (NASDAQ:DCOM), Xinyuan Real Estate (NYSE:XIN)

America Movil SAB de CV (NYSE:AMX) has received an average rating of “Hold” from the nine ratings firms that are covering the stock. America Movil S.A.B. de C.V. (NYSE:AMX) belongs to Technology sector. Its net profit margin is 13.60% and weekly performance is 3.91%. On last trading day company shares ended up $24.17. America Movil S.A.B. de C.V. (NYSE:AMX) distance from 50-day simple moving average … Continue reading News Buzz: America Movil (NYSE:AMX), Verizon Communications Inc. (NYSE:VZ), Amicus Therapeutics, Inc. (NASDAQ:FOLD), Dime Community Bancshares Inc. (NASDAQ:DCOM), Xinyuan Real Estate (NYSE:XIN)

Colin Pettis11/24

Worth Watching Stocks : AbbVie Inc. (NYSE:ABBV), Alcatel Lucent SA (ADR) (NYSE:ALU), SCANA Corp. (NYSE:SCG), Amicus Therapeutics, Inc. (NASDAQ:FOLD), AutoZone, Inc. (NYSE:AZO)

AbbVie Inc. (NASDAQ:ABBV) declared a quarterly dividend on Friday, September 19th. Stockholders of record on Wednesday, October 15th will be given a dividend of 0.42 per share on Monday, November 17th. This represents a $1.68 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date of this dividend is Friday, October 10th. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit … Continue reading Worth Watching Stocks : AbbVie Inc. (NYSE:ABBV), Alcatel Lucent SA (ADR) (NYSE:ALU), SCANA Corp. (NYSE:SCG), Amicus Therapeutics, Inc. (NASDAQ:FOLD), AutoZone, Inc. (NYSE:AZO)

Kevin Long10/10

Top News : GoPro (NASDAQ:GPRO), Amicus Therapeutics (NASDAQ:FOLD), ABIOMED(NASDAQ:ABMD), Veracyte, Inc. (NASDAQ:VCYT), Brown Shoe Co. Inc. (NYSE:BWS)

GoPro, Inc. (NASDAQ:GPRO) on July 31 announced financial results for its second quarter ended June 30, 2014. Revenue in the second quarter of 2014 was $244.6 million, up 38.1% compared to the $177.1 million reported in the second quarter of 2013. Non-GAAP net income in the second quarter of 2014 was $11.8 million or $0.08 per diluted share, compared to a net loss of ($3.2) … Continue reading Top News : GoPro (NASDAQ:GPRO), Amicus Therapeutics (NASDAQ:FOLD), ABIOMED(NASDAQ:ABMD), Veracyte, Inc. (NASDAQ:VCYT), Brown Shoe Co. Inc. (NYSE:BWS)

John Meady09/02

Morning Alert: Amicus Therapeutics (NASDAQ:FOLD), EMC (NYSE:EMC), Rubicon Technology (NASDAQ:RBCN), Quest Rare Minerals Ltd. (NYSEMKT:QRM), Vera Bradley, Inc. (NASDAQ:VRA)

Amicus Therapeutics, Inc. (NASDAQ:FOLD) currently has a Zacks Rank #2 (Buy). Amicus Therapeutics, Inc. (NASDAQ:FOLD) belongs to Healthcare sector. Its weekly performance is 34.38%. On last trading day company shares ended up $7.27. Amicus Therapeutics, Inc. (NASDAQ:FOLD) distance from 50-day simple moving average (SMA50) is 76.12%. EMC (NYSE:EMC) declared a quarterly dividend on Friday, August 1st. Investors of record on Wednesday, October 1st will be given … Continue reading Morning Alert: Amicus Therapeutics (NASDAQ:FOLD), EMC (NYSE:EMC), Rubicon Technology (NASDAQ:RBCN), Quest Rare Minerals Ltd. (NYSEMKT:QRM), Vera Bradley, Inc. (NASDAQ:VRA)

Jason Knox08/29